Epigenetics and beyond: targeting writers of protein lysine methylation to treat disease

KP Bhat, H Ümit Kaniskan, J Jin… - Nature Reviews Drug …, 2021 - nature.com
Protein lysine methylation is a crucial post-translational modification that regulates the
functions of both histone and non-histone proteins. Deregulation of the enzymes or 'writers' …

Epigenetic alterations and inflammation as emerging use for the advancement of treatment in non-small cell lung cancer

S Yang, Y Huang, Q Zhao - Frontiers in Immunology, 2022 - frontiersin.org
Lung cancer remains one of the most common malignancies in the world. Nowadays, the
most common lung cancer is non-small cell lung cancer (NSCLC), namely …

[HTML][HTML] Epigenomic state transitions characterize tumor progression in mouse lung adenocarcinoma

LM LaFave, VK Kartha, S Ma, K Meli, I Del Priore… - Cancer cell, 2020 - cell.com
Regulatory networks that maintain functional, differentiated cell states are often dysregulated
in tumor development. Here, we use single-cell epigenomics to profile chromatin state …

EHMT1/EHMT2 in EMT, cancer stemness and drug resistance: emerging evidence and mechanisms

A Nachiyappan, N Gupta, R Taneja - The FEBS Journal, 2022 - Wiley Online Library
Metastasis, therapy failure and tumour recurrence are major clinical challenges in cancer.
The interplay between tumour‐initiating cells (TICs) and epithelial–mesenchymal transition …

The application of patient-derived organoid in the research of lung cancer

Y Li, X Gao, C Ni, B Zhao, X Cheng - Cellular Oncology, 2023 - Springer
Lung cancer is the most common cancer and the leading cause of cancer-related death
worldwide. However, mechanisms of its progression remained unclear and new treatments …

SPOP mutation induces DNA methylation via stabilizing GLP/G9a

J Zhang, K Gao, H Xie, D Wang, P Zhang, T Wei… - Nature …, 2021 - nature.com
Mutations in SPOP E3 ligase gene are reportedly associated with genome-wide DNA
hypermethylation in prostate cancer (PCa) although the underlying mechanisms remain …

Emerging role of G9a in cancer stemness and promises as a therapeutic target

JR Haebe, CJ Bergin, T Sandouka, YD Benoit - Oncogenesis, 2021 - nature.com
The histone methyltransferase G9a is well-documented for its implication in neoplastic
growth. However, recent investigations have demonstrated a key involvement of this …

Targeting lipid metabolism in cancer metastasis

G Pascual, B Majem, SA Benitah - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
This review delves into the most recent research on the metabolic adaptability of cancer
cells and examines how their metabolic functions can impact their progression into …

Microbiome dysbiosis and epigenetic modulations in lung cancer: from pathogenesis to therapy

FH Khan, BA Bhat, BA Sheikh, L Tariq… - Seminars in Cancer …, 2022 - Elsevier
The lung microbiome plays an essential role in maintaining healthy lung function, including
host immune homeostasis. Lung microbial dysbiosis or disruption of the gut-lung axis can …

[HTML][HTML] The roles of histone modifications in tumorigenesis and associated inhibitors in cancer therapy

Y Yang, M Zhang, Y Wang - Journal of the National Cancer Center, 2022 - Elsevier
Histone modifications are key factors in chromatin packaging, and are responsible for gene
regulation during cell fate determination and development. Abnormal alterations in histone …